YL

Yanke Liang

DI Dana-Farber Cancer Institute: 4 patents #11 of 232Top 5%
CT C4 Therapeutics: 3 patents #1 of 10Top 10%
📍 Belmont, MA: #4 of 230 inventorsTop 2%
🗺 Massachusetts: #342 of 14,474 inventorsTop 3%
Overall (2020): #16,077 of 565,922Top 3%
7
Patents 2020

Issued Patents 2020

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
10870651 Inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Tinghu Zhang, Nicholas Paul Kwiatkowski 2020-12-22
10865204 Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Nicholas Paul Kwiatkowski, Baishan Jiang +1 more 2020-12-15
10865205 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Nicholas Paul Kwiatkowski 2020-12-15
10849982 C3-carbon linked glutarimide degronimers for target protein degradation Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Minsheng He, Kiel Lazarski +2 more 2020-12-01
10660968 Spirocyclic degronimers for target protein degradation Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Kiel Lazarski, Ryan E. Michael 2020-05-26
10646575 Heterocyclic degronimers for target protein degradation Andrew J. Phillips, Chris G. Nasveschuk, James A. Henderson, Mark Fitzgerald, Minsheng He +1 more 2020-05-12
10532103 Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Tinghu Zhang, Calla M. Olson, Nicholas Paul Kwiatkowski 2020-01-14